Skip to main content
Clinical Trials/NCT04785274
NCT04785274
Completed
Not Applicable

The Effect of Non-invasive Hemoglobin Measurement on Blood Transfusion and Mortality in Hip Surgeries: a Randomized Controlled Trial

Bulent Ecevit University1 site in 1 country40 target enrollmentJanuary 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bleeding
Sponsor
Bulent Ecevit University
Enrollment
40
Locations
1
Primary Endpoint
Hemodynamic Stability
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Bleeding is one of the most important causes of mortality and morbidity in patients.

Hb levels are the most prevalently utilized monitoring parameter in hemorrhagic patients in the hemodynamic sense. Hemoglobin determination is studied at laboratories along with blood gasses or complete blood analysis. Recently, non-invasive techniques where measurement is made from the fingertips have been offered for use. One of these techniques is non-invasive hemoglobin (SpHb) measurement. SpHb is used as a trend monitor. Based on the severity of bleeding, the compensatory mechanisms of patients may be disrupted. This situation may lead to lower levels of toleration of anemia during bleeding. The relationship between blood transfusion and mortality is under debate.

Registry
clinicaltrials.gov
Start Date
January 1, 2021
End Date
December 31, 2021
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Bulent Ecevit University
Responsible Party
Principal Investigator
Principal Investigator

OZCAN PISKIN, MD

Clinical Professor

Bulent Ecevit University

Eligibility Criteria

Inclusion Criteria

  • 18-60 years old
  • General anesthesia undergoing hip surgery
  • American society of anesthesiology (ASA) scores I-II-III

Exclusion Criteria

  • Receiving inotropic support
  • Uncontrolled diabetes
  • Arrhythmia
  • Hypothermia
  • Hyperbilirubinemia
  • Dark skin pigmentation
  • Without voluntary consent
  • Hypovolemia,
  • hypotension,
  • blood diseases

Outcomes

Primary Outcomes

Hemodynamic Stability

Time Frame: during the surgery

to compare blood transfusion decisions made with SpHb measurement values and with conventional methods in patient who would receive hip surgery.

Secondary Outcomes

  • Mortality(until 3 months after surgery)

Study Sites (1)

Loading locations...

Similar Trials